ALXO

Conviction 65HealthcareScan · Thu, Jun 25, 2026

Three white soldiers

ALXO$1.80+0.56%

ResistanceSupportVol 14

Vol MA14 1.52M

Mar 26Apr 14May 1May 19Jun 8Jun 25

ALX ONCOLOGY HOLDINGS INCPHARMACEUTICAL PREPARATIONSwww.alxoncology.com ↗

Price1.80

Change+0.56%

Gap+0.00%

Rel volume2.38×

Avg volume1.42M

Avg $ vol2.3M

SMA 201.64

SMA 501.77

SMA 2001.70

Price vs 50+1.98%

Price vs 200+6.17%

MA stackbullish

50/200 cross—

Supertrendup · 1.42

RSI (14)56

MACD hist0.04

MACD crossbull · 2d

Stoch %K / %D80 / 89

ADX (14)30

+DI / −DI26 / 20

RSI divergence—

MACD divergence—

ATR %+7.34%

ADR %7.70%

52w high2.60

52w low0.4058

From 52w high-30.77%

Above 52w low+343.57%

New 52w highNo

SqueezeOff

Bollinger width36.15%

%B0.78

Donchian pos69.35%

Donchian high1.99

Donchian low1.37

AVWAP (52w high)1.86

vs AVWAP high-3.13%

AVWAP (52w low)1.52

vs AVWAP low+18.54%

OBV trendFlat

Chaikin MF (20)-0.13

Today vs 20d2.38×

Avg vol (14d)1.52M

Avg vol (20d)1.42M

Avg $ vol (20d)2.3M

Market cap242.21M

RS 3m (vs SPY)-24.51%

RS 6m (vs SPY)+15.71%

RS line new highNo

Trend template6/8

Technical rank66.0

1 week+24.14%

1 month-6.74%

3 months-11.76%

6 months+20.81%

1 year+295.52%

YTD+56.52%

P/E-2.38

P/B1.60

P/S—

P/FCF-2.87

EPS-1.90

Div yield—

ROE-67.19%

ROA-57.03%

Debt/Eq0.06

Current7.21

EV/EBITDA-2.11

Gross margin—

Net margin—

Rev growth—

EPS growth24.59%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value218.44M

Revenue527K

Net income-17.93M

Gross profit—

Free cash flow-84.35M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out134.56M

Employees43

ListedFri, Jul 17, 2020

Free float92.52M

Float %68.8%

Short interest1.71M

Days to cover1.3d

Short volume57.0%

Squeeze score37 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.17 vs −$0.15

Last surprise-13.3% miss

Setup gradeB

Conviction65 / 100

Pattern quality—

Tech rank66.0 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmThree white soldiers

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ALXO

All disclosures →

No recent disclosed trades by Congress in ALXO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ALXO · 2 buys

Insider	Side	Shares	Value	Traded	Filed
Klencke Barbara Chief Medical Officer · Stock option (right to buy) · 2026-04-16	Grant	100K	$0	2026-04-16	2026-04-17
Knight Jeff E. Chief Dev & Operating Officer · Stock option (right to buy) · 2026-04-16	Grant	800K	$0	2026-04-16	2026-04-17

SEC filings

EDGAR filings in ALXO · 1 recent

EDGAR →

8-K8-KThu, Jun 11, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.